These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6749582)

  • 21. Metformin normalizes insulin binding to monocytes from obese nondiabetic subjects and obese type II diabetic patients.
    Trischitta V; Gullo D; Pezzino V; Vigneri R
    J Clin Endocrinol Metab; 1983 Oct; 57(4):713-8. PubMed ID: 6350337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new alpha-glucosidase inhibitor (Bay-m-1099) reduces insulin requirements with meals in insulin-dependent diabetes mellitus.
    Kennedy FP; Gerich JE
    Clin Pharmacol Ther; 1987 Oct; 42(4):455-8. PubMed ID: 3311550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group.
    Fontbonne A; Charles MA; Juhan-Vague I; Bard JM; André P; Isnard F; Cohen JM; Grandmottet P; Vague P; Safar ME; Eschwège E
    Diabetes Care; 1996 Sep; 19(9):920-6. PubMed ID: 8875083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with type II diabetes (UKPDS No. 51).
    Clarke P; Gray A; Adler A; Stevens R; Raikou M; Cull C; Stratton I; Holman R;
    Diabetologia; 2001 Mar; 44(3):298-304. PubMed ID: 11317659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.
    Avilés-Santa L; Sinding J; Raskin P
    Ann Intern Med; 1999 Aug; 131(3):182-8. PubMed ID: 10428734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of insulin and metformin in the treatment of type 2 diabetes.
    Wulffelé MG; Kooy A; Lehert P; Bets D; Ogterop JC; Borger van der Burg B; Donker AJ; Stehouwer CD
    Diabetes Care; 2002 Dec; 25(12):2133-40. PubMed ID: 12453950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glucose control in mobile type 1 (insulin-dependent) diabetic patients by means of a semi-automatic feedback controlled insulin infusion system.
    Piwernetz K; Renner R; Hepp KD
    Diabetologia; 1982 Sep; 23(3):229-34. PubMed ID: 7128971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The metabolic and hormonal response to acute normoglycaemia in type 1 (insulin-dependent) diabetes: studies with a glucose controlled insulin infusion system (artificial endocrine pancreas).
    Nosadini R; Noy GA; Nattrass M; Alberti KG; Johnston DG; Home PD; Orskov H
    Diabetologia; 1982 Sep; 23(3):220-8. PubMed ID: 6751902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety, efficacy and glucose turnover of reduced prandial boluses during closed-loop therapy in adolescents with type 1 diabetes: a randomized clinical trial.
    Elleri D; Biagioni M; Allen JM; Kumareswaran K; Leelarathna L; Caldwell K; Nodale M; Wilinska ME; Haidar A; Calhoun P; Kollman C; Jackson NC; Umpleby AM; Acerini CL; Dunger DB; Hovorka R
    Diabetes Obes Metab; 2015 Dec; 17(12):1173-9. PubMed ID: 26257323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mathematical modeling shows exenatide improved beta-cell function in patients with type 2 diabetes treated with metformin or metformin and a sulfonylurea.
    Mari A; Nielsen LL; Nanayakkara N; DeFronzo RA; Ferrannini E; Halseth A
    Horm Metab Res; 2006 Dec; 38(12):838-44. PubMed ID: 17163361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin responses to mixed meals: comparison of an artificial beta cell and normal beta cells.
    Horwitz DL
    Horm Metab Res Suppl; 1979; (8):68-71. PubMed ID: 395093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant glucagon-like peptide-1 (7-36 amide) lowers fasting serum glucose in a broad spectrum of patients with type 2 diabetes.
    Ehlers MR; Klaff LJ; D'Alessio DA; Brazg R; Kay HD; Harley RE; Mathisen AL; Schneider R
    Horm Metab Res; 2003 Oct; 35(10):611-6. PubMed ID: 14605997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K; Kipnes M; Luo E; Fanurik D; Khatami H; Stein P;
    Diabetes Obes Metab; 2007 Sep; 9(5):733-45. PubMed ID: 17593236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reproducibility of insulin dosage on consecutive days of blood glucose control by an artificial beta-cell in brittle diabetic patients.
    Bruns W; Bombor H; Jutzi E; Ratzmann KP; Schulz B; Abel P; Fischer U
    Diabetes Care; 1983; 6(2):112-7. PubMed ID: 6343014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between the nature and amount of carbohydrate in meal intake and insulin delivery by the artificial pancreas in 24 insulin-dependent diabetics.
    Slama G; Klein JC; Delage A; Ardila E; Lemaignen H; Papoz L; Tchobroutsky G
    Diabetes; 1981 Feb; 30(2):101-5. PubMed ID: 7009264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of acarbose on post-prandial insulin requirements in patients with Type 1 diabetes.
    Juntti-Berggren L; Pigon J; Hellström P; Holst JJ; Efendic S
    Diabetes Nutr Metab; 2000 Feb; 13(1):7-12. PubMed ID: 10824717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
    Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
    Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [New clinical data with metformin therapy in patients with diabetes mellitus].
    Jermendy G
    Orv Hetil; 2010 Dec; 151(49):2025-30. PubMed ID: 21106483
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.